ILGEN Inc

March 27, 2020: ILGEN Inc. will discover and develop fully human neutralizing antibodies targeting SARS-CoV-2 to potentially prevent or treat COVID-19.

  • Stage Product In Development
  • Industry Healthcare Services
  • Location Syracuse, NY, USA
  • Currency USD
  • Founded March 2016
  • Employees 3
  • Incorporation Type C-corp
  • Website ilgenbio.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free